E
Ermias Diro
Researcher at Institute of Tropical Medicine Antwerp
Publications - 13
Citations - 343
Ermias Diro is an academic researcher from Institute of Tropical Medicine Antwerp. The author has contributed to research in topics: Visceral leishmaniasis & Leishmaniasis. The author has an hindex of 8, co-authored 13 publications receiving 297 citations.
Papers
More filters
Journal ArticleDOI
Visceral Leishmaniasis and HIV coinfection in East Africa.
TL;DR: Basic research to understand the immunological interaction of the two infections may ultimately help to improve the management of the coinfection.
Journal ArticleDOI
High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia
TL;DR: SSG is not only unsafe, but also has low effectiveness for VL-HIV patients, and safe and effective alternative medications are very urgently needed.
Journal ArticleDOI
Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
Ermias Diro,Koert Ritmeijer,Marleen Boelaert,Fabiana Alves,Rezika Mohammed,Charles Abongomera,Raffaella Ravinetto,Maaike De Crop,Helina Fikre,Cherinet Adera,Robert Colebunders,Harry van Loen,Joris Menten,Lutgarde Lynen,Asrat Hailu,Johan van Griensven +15 more
TL;DR: Pentamidine secondary prophylaxis led to a 29% failure rate within one year, much lower than reported in historical controls (50%-100%).
Journal ArticleDOI
Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia.
Mengistu Endris,Yegnasew Takele,Desalegn Woldeyohannes,Moges Tiruneh,Rezika Mohammed,Feleke Moges,Lutgarde Lynen,Jan Jacobs,Johan van Griensven,Ermias Diro +9 more
TL;DR: Careful clinical evaluation for focal infections and prompt initiation of empiric antibiotic treatment appears warranted in VL patients, suggesting that focal infections could serve as sources for bacterial sepsis among Vl patients.
Journal ArticleDOI
A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?
Johan van Griensven,Ermias Diro,Rogelio López-Vélez,Koert Ritmeijer,Marleen Boelaert,Ed E. Zijlstra,Asrat Hailu,Lutgarde Lynen +7 more
TL;DR: Tackling L. donovani infection before disease onset would thus be a logical approach, and should be complemented with early initiation of antiretroviral treatment and other strategies to prevent HIV and Leishmania infection.